title: Personalizing medicine with clinical pharmacogenetics.
abstract: Clinical genetic testing has grown substantially over the past 30 years as the causative mutations for Mendelian diseases have been identified, particularly aided in part by the recent advances in molecular-based technologies. Importantly, the adoption of new tests and testing strategies (e.g., diagnostic confirmation, prenatal testing, and population-based carrier screening) has often been met with caution and careful consideration before clinical implementation, which facilitates the appropriate use of new genetic tests. Although the field of pharmacogenetics was established in the 1950s, clinical testing for constitutional pharmacogenetic variants implicated in interindividual drug response variability has only recently become available to help clinicians guide pharmacotherapy, in part due to US Food and Drug Administration-mediated product insert revisions that include pharmacogenetic information for selected drugs. However, despite pharmacogenetic associations with adverse outcomes, physician uptake of clinical pharmacogenetic testing has been slow. Compared with testing for Mendelian diseases, pharmacogenetic testing for certain indications can have a lower positive predictive value, which is one reason for underutilization. A number of other barriers remain with implementing clinical pharmacogenetics, including clinical utility, professional education, and regulatory and reimbursement issues, among others. This review presents some of the current opportunities and challenges with implementing clinical pharmacogenetic testing.
authors.affiliation: Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, USA. stuart.scott@mssm.edu
authors.forename: Stuart A
authors.initials: SA
authors.lastname: Scott
mesh_terms: D000483:Alleles; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics* / Q000378:metabolism; D005006:Ethnicity / Q000235:genetics; D019317:Evidence-Based Medicine; D005787:Gene Frequency; D005820:Genetic Testing; D014644:Genetic Variation; D006801:Humans; D010597:Pharmacogenetics / Q000191:economics / Q000639:trends*; D057285:Precision Medicine / Q000191:economics / Q000639:trends*; D011237:Predictive Value of Tests; D055553:Prescription Drugs / Q000378:metabolism; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D055553:Prescription Drugs; D019389:Cytochrome P-450 CYP2D6
references.citation: Lancet Oncol. 2010 Jun;11(6):507-9
references.pmid: 20413348
references.citation: J Biol Chem. 1994 Jun 3;269(22):15419-22
references.pmid: 8195181
references.citation: Hum Genomics. 2010 Apr;4(4):278-81
references.pmid: 20511141
references.citation: Per Med. 2009 Jul;6(4):359-361
references.pmid: 29783536
references.citation: Acta Psychiatr Scand. 2001 Sep;104(3):173-92
references.pmid: 11531654
references.citation: Pharmacotherapy. 2011 Aug;31(8):729-35
references.pmid: 21923598
references.citation: Clin Pharmacol Ther. 2011 Jun;89(6):924-7
references.pmid: 21508939
references.citation: Pharmacogenomics. 2011 May;12(5):597-610
references.pmid: 21619425
references.citation: Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5237-41
references.pmid: 1675794
references.citation: Genet Med. 2005 Sep;7(7):495-500
references.pmid: 16170241
references.citation: Genet Med. 2011 Oct;13(10):866-7
references.pmid: 21799428
references.citation: Nat Rev Genet. 2010 Apr;11(4):241-6
references.pmid: 20300088
references.citation: N Engl J Med. 2011 Mar 24;364(12):1134-43
references.pmid: 21428769
references.citation: Genet Med. 2007 Dec;9(12):819-25
references.pmid: 18091431
references.citation: Pharmacogenet Genomics. 2005 Oct;15(10):677-85
references.pmid: 16141793
references.citation: Anesthesiology. 1964 May-Jun;25:377-87
references.pmid: 14156579
references.citation: Clin Pharmacol Ther. 2011 May;89(5):662-73
references.pmid: 21412232
references.citation: Br J Clin Pharmacol. 2010 Mar;69(3):222-30
references.pmid: 20233192
references.citation: N Engl J Med. 2008 Aug 21;359(8):789-99
references.pmid: 18650507
references.citation: Nature. 2009 Sep 17;461(7262):399-401
references.pmid: 19684573
references.citation: Ann Intern Med. 2003 Apr 1;138(7):571-5
references.pmid: 12667027
references.citation: Pharmacogenomics. 2010 Sep;11(9):1331-40
references.pmid: 20860470
references.citation: Psychosomatics. 2006 Jan-Feb;47(1):75-85
references.pmid: 16384813
references.citation: Hum Mutat. 2005 Nov;26(5):399-412
references.pmid: 16138310
references.citation: Pharmacogenomics J. 2006 Jan-Feb;6(1):16-21
references.pmid: 16302022
references.citation: Nature. 2009 Oct 8;461(7265):724-6
references.pmid: 19812653
references.citation: JAMA. 2008 Mar 19;299(11):1320-34
references.pmid: 18349093
references.citation: Clin Pharmacol Ther. 2010 Jan;87(1):109-16
references.pmid: 19940846
references.citation: Pharmacogenomics. 2010 Jun;11(6):781-91
references.pmid: 20504253
references.citation: Mcgill J Med. 2007 Jan;10(1):53-7
references.pmid: 18523593
references.citation: Lancet. 1977 Sep 17;2(8038):584-6
references.pmid: 71400
references.citation: Clin Pharmacol Ther. 2011 Mar;89(3):387-91
references.pmid: 21270794
references.citation: Clin Pharmacol Ther. 2010 Dec;88(6):749-51
references.pmid: 21081943
references.citation: Am J Hum Genet. 2008 Feb;82(2):495-500
references.pmid: 18252229
references.citation: Blood. 2008 Aug 15;112(4):1022-7
references.pmid: 18535201
references.citation: J Mol Diagn. 2010 Nov;12(6):835-46
references.pmid: 20889555
references.citation: Nat Rev Cardiol. 2009 May;6(5):334-6
references.pmid: 19377495
references.citation: Methods Mol Biol. 2010;632:99-124
references.pmid: 20217574
references.citation: Clin Pharmacol Ther. 2011 Mar;89(3):348-50
references.pmid: 21326263
references.citation: Drug Metab Rev. 2008;40(4):539-51
references.pmid: 18949600
references.citation: Pharmacogenomics. 2008 Nov;9(11):1573-7
references.pmid: 19018710
references.citation: N Engl J Med. 2009 Feb 19;360(8):753-64
references.pmid: 19228618
references.citation: Med Decis Making. 2010 May-Jun;30(3):328-40
references.pmid: 20086232
references.citation: Genet Med. 2009 Jan;11(1):15-20
references.pmid: 19125128
references.citation: Pharmacogenet Genomics. 2009 Jul;19(7):559-62
references.pmid: 19512959
references.citation: Clin Pharmacol Ther. 2011 Oct;90(4):625-9
references.pmid: 21900891
references.citation: Blood. 2010 May 6;115(18):3827-34
references.pmid: 20203262
references.citation: Pharmacogenet Genomics. 2013 Aug;23(8):383-94
references.pmid: 20639796
references.citation: Clin Pharmacol Ther. 2011 Mar;89(3):464-7
references.pmid: 21270786
references.citation: Clin Pharmacokinet. 1982 Sep-Oct;7(5):373-400
references.pmid: 6754206
references.citation: Genet Med. 2009 Jan;11(1):3-14
references.pmid: 18813139
references.citation: Annu Rev Pharmacol Toxicol. 2001;41:815-50
references.pmid: 11264478
references.citation: Clin Pharmacol Ther. 2010 Dec;88(6):867-70
references.pmid: 20981004
references.citation: Lancet. 1978 Oct 28;2(8096):910-2
references.pmid: 81926
references.citation: N Engl J Med. 2011 Mar 24;364(12):1126-33
references.pmid: 21428768
references.citation: Pharmacogenomics. 2003 Mar;4(2):201-7
references.pmid: 12605554
references.citation: J Clin Oncol. 2009 Dec 10;27(35):5972-8
references.pmid: 19901119
references.citation: Mol Diagn Ther. 2009;13(1):1-9
references.pmid: 19351209
references.citation: Hum Mutat. 2010 Nov;31(11):1240-50
references.pmid: 20672374
references.citation: Clin Pharmacol Ther. 2010 Dec;88(6):729-33
references.pmid: 21081937
references.citation: JAMA. 2010 Oct 27;304(16):1821-30
references.pmid: 20978260
references.citation: Genet Med. 2009 Aug;11(8):575-6
references.pmid: 19623080
references.citation: Am J Hematol. 1993 Jan;42(1):53-8
references.pmid: 8416297
references.citation: Clin Pharmacol Ther. 2008 Sep;84(3):326-31
references.pmid: 18305455
references.citation: Clin Pharmacol Ther. 2008 Sep;84(3):332-9
references.pmid: 18596683
references.citation: Pharmacogenomics. 2009 Feb;10(2):161-3
references.pmid: 19207016
references.citation: Clin Pharmacol Ther. 2012 Feb;91(2):321-6
references.pmid: 22205192
references.citation: Clin Pharmacol Ther. 2011 Aug;90(2):328-32
references.pmid: 21716271
references.citation: Pharmacogenet Genomics. 2008 Apr;18(4):367-8
references.pmid: 18334921
references.citation: Clin Pharmacol Ther. 2010 Jun;87(6):635-8
references.pmid: 20485318
references.citation: Pharmacogenomics. 2010 Apr;11(4):507-12
references.pmid: 20350131
references.citation: Genet Med. 2008 Feb;10(2):139-50
references.pmid: 18281922
references.citation: PLoS Genet. 2009 Mar;5(3):e1000433
references.pmid: 19300499
references.citation: J Am Med Assoc. 1957 Oct 19;165(7):835-7
references.pmid: 13462859
references.citation: J Am Coll Cardiol. 2010 Jul 20;56(4):321-41
references.pmid: 20633831
references.citation: Pharmacogenomics. 2010 Jul;11(7):989-1002
references.pmid: 20602617
references.citation: Nat Genet. 2009 Jul;41(7):816-9
references.pmid: 19483685
references.citation: Pharmacotherapy. 2008 Aug;28(8):992-8
references.pmid: 18657016
references.citation: PLoS One. 2011 May 04;6(5):e19166
references.pmid: 21573225
references.citation: Pharmacogenomics. 2011 Jan;12(1):113-24
references.pmid: 21174626
references.citation: JAMA. 2009 Aug 26;302(8):849-57
references.pmid: 19706858
references.citation: Pharmacogenomics. 2011 Jan;12(1):49-58
references.pmid: 21174622
references.citation: Expert Opin Pharmacother. 2011 Feb;12(3):435-41
references.pmid: 21231897